Keyword
Menu
Home
About
Introducing Spineopedia
How We Score
Editors
Study Reviews
Resources
Spine Meetings
Calendar
Contact
Asterias Biotherapeutics Receives Safety Clearance to Begin Administering the Highest Dose of AST-OPC1 in the SCiStar Phase 1/2a Clinical Trial in Cervical Spinal Cord Injury Patients
Share
Posted:
August 31, 2016 at 7:00 pm / by
admin
/
comments (0)
tags:
Keyword
Recent Comments
Recent Comments